Seguir
R Rupaimoole
R Rupaimoole
Dirección de correo verificada de bayer.com
Título
Citado por
Citado por
Año
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
R Rupaimoole, FJ Slack
Nature reviews Drug discovery 16 (3), 203-222, 2017
41762017
Paraneoplastic thrombocytosis in ovarian cancer
RL Stone, AM Nick, IA McNeish, F Balkwill, HD Han, J Bottsford-Miller, ...
New England Journal of Medicine 366 (7), 610-618, 2012
8272012
miRNA deregulation in cancer cells and the tumor microenvironment
R Rupaimoole, GA Calin, G Lopez-Berestein, AK Sood
Cancer discovery 6 (3), 235-246, 2016
6382016
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer
D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ...
Cancer cell 23 (2), 186-199, 2013
4432013
Tumour angiogenesis regulation by the miR-200 family
CV Pecot, R Rupaimoole, D Yang, R Akbani, C Ivan, C Lu, S Wu, HD Han, ...
Nature communications 4 (1), 2427, 2013
4302013
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
L Yang, T Moss, LS Mangala, J Marini, H Zhao, S Wahlig, G Armaiz‐Pena, ...
Molecular systems biology 10 (5), 728, 2014
3402014
Hematogenous metastasis of ovarian cancer: rethinking mode of spread
S Pradeep, SW Kim, SY Wu, M Nishimura, P Chaluvally-Raghavan, ...
Cancer cell 26 (1), 77-91, 2014
3342014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ...
Nature communications 5 (1), 5203, 2014
2302014
Autocrine effects of tumor-derived complement
MS Cho, HG Vasquez, R Rupaimoole, S Pradeep, S Wu, B Zand, HD Han, ...
Cell reports 6 (6), 1085-1095, 2014
2062014
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
M Haemmerle, ML Taylor, T Gutschner, S Pradeep, MS Cho, J Sheng, ...
Nature communications 8 (1), 310, 2017
2022017
Role of focal adhesion kinase in regulating YB–1–mediated paclitaxel resistance in ovarian cancer
Y Kang, W Hu, C Ivan, HJ Dalton, T Miyake, CV Pecot, B Zand, T Liu, ...
Journal of the National Cancer Institute 105 (19), 1485-1495, 2013
1822013
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression
R Rupaimoole, SY Wu, S Pradeep, C Ivan, CV Pecot, KM Gharpure, ...
Nature communications 5 (1), 5202, 2014
1792014
FABP4 as a key determinant of metastatic potential of ovarian cancer
KM Gharpure, S Pradeep, M Sans, R Rupaimoole, C Ivan, SY Wu, ...
Nature communications 9 (1), 1-14, 2018
1642018
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers
K Van Roosbroeck, F Fanini, T Setoyama, C Ivan, C Rodriguez-Aguayo, ...
Clinical Cancer Research 23 (11), 2891-2904, 2017
1472017
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
SY Wu, R Rupaimoole, F Shen, S Pradeep, CV Pecot, C Ivan, ...
Nature communications 7 (1), 11169, 2016
1352016
2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity
SY Wu, X Yang, KM Gharpure, H Hatakeyama, M Egli, MH McGuire, ...
Nature communications 5 (1), 3459, 2014
1282014
Yes‐associated protein 1 and transcriptional coactivator with PDZ‐binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid …
YY Park, BH Sohn, RL Johnson, MH Kang, SB Kim, JJ Shim, LS Mangala, ...
Hepatology 63 (1), 159-172, 2016
1272016
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers
G Liu, D Yang, R Rupaimoole, CV Pecot, Y Sun, LS Mangala, X Li, P Ji, ...
JNCI: Journal of the National Cancer Institute 107 (7), djv108, 2015
1252015
miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016; 6: 235–246. doi: 10.1158/2159-8290
R Rupaimoole, GA Calin, G Lopez-Berestein, AK Sood
CD-15-0893.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
124
MiR‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer
Y Sun, L Hu, H Zheng, M Bagnoli, Y Guo, R Rupaimoole, ...
The Journal of pathology 235 (1), 25-36, 2015
1202015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20